Profiel
K.
Chris Min worked as a Senior Medical Director-Neurology at Bluerock Therapeutics, Inc. and as VP, Head-Medical & Clinical Development at Enterin, Inc. In 2023, he served as the Chief Medical Officer at Longeveron, Inc. Dr. Min completed his undergraduate degree at Harvard University and earned his doctorate degrees from The Rockefeller University and Weill Cornell Medical College.
Eerdere bekende functies van K. Min
| Bedrijven | Functie | Einde |
|---|---|---|
| LONGEVERON INC. | Chief Executive Officer | 01-03-2023 |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 01-04-2021 |
| Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - |
Opleiding van K. Min
| Harvard University | Undergraduate Degree |
| The Rockefeller University | Doctorate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
| Bluerock Therapeutics, Inc. |
